default author photo

Premal Thaker

Siteman Cancer Center

SCHOLARLY PAPERS

5

DOWNLOADS

253

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Genomic Alterations, Molecularly Targeted Therapy, and Survival: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 33 Posted: 14 Aug 2024
Angeles Alvarez Secord, Victoria L. Bae-Jump, Floor J. Backes, Premal Thaker, Paola Gehrig, Rebecca A. Previs, Lindsay Borden, Samantha Thomas, Amanda Jackson, Gottfried E. Konecny, Linda Duska, Rebecca C. Arend, Jason D. Wright, Bradley R. Corr, G.Larry Maxwell, Casey Cosgrove, Maggie Mullen, Christina Washington, Thomas Herzog, Joshua G. Cohen, June Hou, Stephanie Gaillard, Amanda N. Fader, Andrew Berchuck and Franco Muggia
Duke University, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, affiliation not provided to SSRN, Siteman Cancer Center, affiliation not provided to SSRN, Duke University, University of Oklahoma - University of Oklahoma Health Sciences Center, Duke University, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, University of Virginia, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, Inova Health System - Inova Fairfax Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, affiliation not provided to SSRN, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati, City of Hope National Medical Center, Columbia University - Irving Medical Center, Johns Hopkins University, Johns Hopkins University, Duke University - Medical Center and New York University (NYU) - NYU Langone Health
Downloads 75 (837,727)

Abstract:

Loading...

endometrial cancer, genomic alterations, targeted therapy, survival

2.

Benefit from the Immune Checkpoint Inhibitor Atezolizumab Addition in Poor Prognostic Ovarian Cancer Patients : Imagyn050 Trial

Number of pages: 20 Posted: 11 Feb 2025
Benoit You, Charles Anderson, Sabrina Chiara Cecere, Aurore Carrot, Tashanna Myers, Florian Heitz, Sudarshan Sharma, Fatih Selcukbiricik, Carol Aghajanian, Josefin Fernebro, Stephanie V. Blank, Maria Elena Laudani, Premal Thaker, Mayu Yunokama, Lyndsay Wilmott, Alla Lisyanskaya, Roberto Hegg, Yvette He, Charles Landen, Yvonne G. Lin, Jesus Alarcon and Kathleen N. Moore
Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Uro-Gynecological Medical Oncology, Université de Lyon - Université Claude Bernard Lyon 1, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Koc University - School of Medicine, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, Mount Sinai Health System - Icahn School of Medicine, University of Turin, Siteman Cancer Center, Japanese Foundation for Cancer Research, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Alabama at Birmingham, affiliation not provided to SSRN, Hospital Universitari Son Espases and University of Oklahoma - Stephenson Cancer Center
Downloads 66 (916,100)

Abstract:

Loading...

Ovarian Neoplasms, Immune checkpoint inhibitors, atezolizumab [Supplementary Concept], CA-125 antigen, Prognosis

3.

Racial and Ethnic Differences and Clinical Outcomes of Patients with High Tumor Mutational Burden, High Microsatellite Instability, and Mismatch Repair Deficiency: Real-World Data from the Multi-Institutional Endometrial Cancer Molecularly Targeted Therapy Consortium (Ecmt2)

Number of pages: 29 Posted: 01 May 2025
Sarah S. Lee, Angeles Alvarez Secord, Steven Friedmann, Erinn M. Hade, Carson Smitherman, Nikita Bisht, Lindsay Borden, Amanda Jackson, Floor J. Backes, Premal Thaker, Rebecca C. Arend, Jason D. Wright, Bradley R. Corr, Emily M. Ko, Gottfried E. Konecny, Sarah Podwika, Victoria L. Bae-Jump, Kari Hacker and Franco Muggia
New York University (NYU) - NYU Langone Health, Duke University, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Duke University - Duke Cancer Institute, Duke University - Duke Cancer Institute, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati - University of Cincinnati Medical Center, affiliation not provided to SSRN, Siteman Cancer Center, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, University of Pennsylvania, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, New York University (NYU) - NYU Langone Health and New York University (NYU) - NYU Langone Health
Downloads 40 (1,183,237)

Abstract:

Loading...

Endometrial cancer, tumor mutational burden, microsatellite instability, mismatch repair deficiency

4.

Diverse Case Series of Granulomatous Peritonitis Mimicking Advanced Ovarian Cancer

Number of pages: 21 Posted: 06 Feb 2025
Rachel Furuya, Bobbie J. Rimel, Richard Tsai, Rebecca Brooks, L. Stewart Massad, Premal Thaker and John D. Pfeifer
affiliation not provided to SSRN, Cedars-Sinai Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Siteman Cancer Center and affiliation not provided to SSRN
Downloads 37 (1,222,651)

Abstract:

Loading...

ovarian cancer, mimic, granulomatous peritonitis

5.

Platinum-Free Interval and Response to Platinum Retreatment or Lenvatinib/Pembrolizumab in Patients with Recurrent Endometrial Cancer: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 19 Posted: 02 Dec 2024
Paulina Haight, Marilyn Sanchez, Samantha Thomas, Carson Smitherman, Casey Cosgrove, Victoria L. Bae-Jump, Sarah M. Crafton, Kari Hacker, Emily M. Ko, Thomas C. Krivak, Olivia Lara, Kathleen N. Moore, Maggie Mullen, Franco Muggia, Premal Thaker, Christina Washington, Rebecca C. Arend, Bradley R. Corr, Linda Duska, Amanda Jackson, Gottfried E. Konecny, Jason Wright, Angeles Alvarez Secord and Floor J. Backes
affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University, Duke University - Duke University Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, Allegheny Health Network, New York University (NYU) - NYU Langone Health, University of Pennsylvania, Allegheny Health Network, affiliation not provided to SSRN, University of Oklahoma - Stephenson Cancer Center, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Siteman Cancer Center, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Alabama at Birmingham, University of Colorado Denver, affiliation not provided to SSRN, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, Duke University and affiliation not provided to SSRN
Downloads 35 (1,249,711)

Abstract:

Loading...

Platinum-free interval, Endometrial Cancer